Literature DB >> 18672122

Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population.

Richard L Tannen, Mark G Weiner, Dawei Xie, Kurt Barnhart.   

Abstract

This commentary integrates the most recent information on coronary heart disease from the Women's Health Initiative (WHI) trial and our new large observational studies, which complement and expand the WHI results to the overall population. Breast and colon cancer findings are also considered.

Entities:  

Mesh：

Year:  2008        PMID： 18672122      PMCID： PMC2560177          DOI： 10.1016/j.fertnstert.2008.05.031

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  14 in total

1.  The truth is out there: a guide to the pitfalls of interpreting evidence-based medicine in studies of human reproduction.

Authors:  Kurt Barnhart; Mary Sammel
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

2.  Understanding the divergent data on postmenopausal hormone therapy.

Authors:  Francine Grodstein; Thomas B Clarkson; JoAnn E Manson
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

3.  Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding.

Authors:  Mark G Weiner; Dawei Xie; Richard L Tannen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-07       Impact factor: 2.890

4.  A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

Authors:  F Grodstein; J E Manson; G A Colditz; W C Willett; F E Speizer; M J Stampfer
Journal:  Ann Intern Med       Date:  2000-12-19       Impact factor: 25.391

5.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

Authors:  F Grodstein; M J Stampfer; J E Manson; G A Colditz; W C Willett; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

6.  A simulation using data from a primary care practice database closely replicated the women's health initiative trial.

Authors:  Richard L Tannen; Mark G Weiner; Dawei Xie; Kurt Barnhart
Journal:  J Clin Epidemiol       Date:  2006-12-27       Impact factor: 6.437

7.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

8.  Estrogen therapy and coronary-artery calcification.

Authors:  Joann E Manson; Matthew A Allison; Jacques E Rossouw; J Jeffrey Carr; Robert D Langer; Judith Hsia; Lewis H Kuller; Barbara B Cochrane; Julie R Hunt; Shari E Ludlam; Mary B Pettinger; Margery Gass; Karen L Margolis; Lauren Nathan; Judith K Ockene; Ross L Prentice; John Robbins; Marcia L Stefanick
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

9.  Replicated studies of two randomized trials of angiotensin-converting enzyme inhibitors: further empiric validation of the 'prior event rate ratio' to adjust for unmeasured confounding by indication.

Authors:  Richard L Tannen; Mark G Weiner; Dawei Xie
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-07       Impact factor: 2.890

10.  Hormone therapy and coronary heart disease in young women.

Authors:  Mark G Weiner; Kurt Barnhart; Dawei Xie; Richard L Tannen
Journal:  Menopause       Date:  2008 Jan-Feb       Impact factor: 2.953
View more
  6 in total

1.  Should hormone replacement therapy be used in postmenopausal women for voiding dysfunction?

Authors:  Lynn Stothers
Journal:  Can Urol Assoc J       Date:  2009-04       Impact factor: 1.862

Review 2.  A heartfelt message, estrogen replacement therapy: use it or lose it.

Authors:  Robert C Speth; Mikayla D'Ambra; Hong Ji; Kathryn Sandberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

3.  Combined hormone therapy at menopause and breast cancer: a warning--short-term use increases risk.

Authors:  Leslie Bernstein
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

4.  Ambulatory Medical Follow-Up in the Year After Surgery and Subsequent Survival in a National Cohort of Veterans Health Administration Surgical Patients.

Authors:  Robert B Schonberger; Feng Dai; Cynthia Brandt; Matthew M Burg
Journal:  J Cardiothorac Vasc Anesth       Date:  2015-12-15       Impact factor: 2.628

5.  A new method to address unmeasured confounding of mortality in observational studies.

Authors:  Richard Tannen; Menggang Yu
Journal:  Learn Health Syst       Date:  2016-12-14

6.  Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings.

Authors:  Richard L Tannen; Mark G Weiner; Dawei Xie
Journal:  BMJ       Date:  2009-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.